Samowitz et al. highlighted that BRAF exon 15 p.V600E mutant CRC patients have a worse prognosis in terms of OS regardless of age, stage (II to IV), and tumor site compared to BRAF wild-type patients [98]. The gene discussed is BRAF; the disease is neoplasm.